GoodRx Expands 'Companion' Subscription to Families, Targets Employer Market in 2027

GoodRx announced on Thursday it is expanding its healthcare subscription service with a new family plan and intends to launch the program as an employee benefit in 2027. The move positions the prescription drug savings company to address growing concerns over healthcare affordability for households and enter the corporate benefits market.

Program Details

The subscription, called Companion, is now available to families for $24.99 per month. The plan provides access to over 250 common generic medications for free, along with discounted telehealth, vision, dental, and lab services. According to a Reuters report, the Companion subscription was previously only offered to individuals at a cost of $14.99 monthly.

GoodRx stated that it is already establishing partnerships with employers to offer the program, with an expected start date of January 1, 2027. A company spokesperson said employers will have the option to subsidize the membership costs, with employees covering any remaining portion.

Addressing Affordability Gaps

Ad

GoodRx CEO Wendy Barnes said the launch is a direct response to the widening healthcare affordability crisis. "Rising deductibles, out-of-pocket costs and coverage restrictions mean that having insurance no longer guarantees affordable access to care," Barnes stated, noting that cost pressures now impact entire households.

This strategy comes as employers face significant cost increases. According to the Business Group on Health, employers anticipate healthcare costs will rise 9.2% in 2027 without mitigating actions. In response, some are considering higher-deductible plans, which shift more initial costs to employees.

Business Context

The expansion into family and employer plans follows a period of strong growth in GoodRx's subscription business. During the second quarter of this year, the company's subscription revenue increased 39% year-over-year. Barnes also noted that consumer uptake for the individual Companion program had surpassed expectations.